quick acting permanent rinderinsulinlsungKRAYENBUEHL, CHARLES HENRY, HELLERUPSCHOU, METTE, LYNGBY
February 29, 2024 Research targeting the insulin-inhibitory receptor, called “inceptor,” unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy. A novel study in mice with diet-induced obesity demonstrates that the knock-out of inceptor enhances glucose regulatio...
quick acting permanent rinderinsulinlsungKRAYENBUEHL, CHARLES HENRY, HELLERUP, DKSCHOU, METTE, LYNBY, DK
The invention relates to a composition in aqueous solution, including insulin and at least one substituted anionic compound chosen from substituted anionic compounds consisting of a backbone formed from a discrete number u of between 1 and 8 (1≦u≦8) of identical or different saccharide units, ...
The invention also provides a coding gene, a cloning vector or an expression vector containing the coding gene, a transformant, and a method for preparing quick-acting insulin by utilization of the quick-acting insulin aspart precursor protein. The expression level of the product is high, the ...
Quick acting insulin preparationJphirgen, Schlichtkrull
US3091573 1958年7月29日 1963年5月28日 Novo Terapeutisk Laboratorium A/S Quick acting insulin preparationUS3091573 1958年7月29日 1963年5月28日 Novo Terapeutisk Labor As Quick acting insulin preparationUS3091573 * Jul 29, 1958 May 28, 1963 Novo Terapeutisk Labor As Quick acting insulin ...
A questionnaire survey on the use of quick- acting insulin analog in Japanese children and adolescents with type 1 diabetes. Pediatr Int. 2004;46(3):285-90.U rakam i T, Kawamura T, Sugihara S, et al. A questionnaire survey on the use of quick2acting insulin analog in Japanese children...
A questionnaire survey on the use of quick- acting insulin analog in Japanese children and adolescents with type 1 diabetes. Pediatr Int. 2004;46(3):285-90.U rakam i T, Kawamura T, Sugihara S, et al. A questionnaire survey on the use of quick2acting insulin analog in Japanese children...
quick acting, bestaendige, neutral insulinloesungenHENRY KRAYENBUEHL CHARLESSCHOU METTE